Autosomal recessive limb-girdle muscular dystrophy type 2W is a subtype of autosomal recessive limb girdle muscular dystrophy characterized by childhood onset of severe, progressive, proximal skeletal...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
The documentation surrounding autosomal recessive limb-girdle muscular dystrophy type 2W is limited due to the rarity of the condition, which affects a small number of individuals globally. This rarity restricts the ability to conduct extensive clinical studies and gather systematic data. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to better understand the full spectrum of the disease.
To navigate the challenges of LGMD2W, seek a neurologist with expertise in muscular dystrophies or neuromuscular disorders. It may also be beneficial to explore genetic counseling services to understand the implications of LIMS2 gene mutations for you and your family. While there are currently no patient organizations specifically for LGMD2W, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, consider participating in any available clinical trials to contribute to research and potentially access new treatment options.
Currently, there are no orphan drug designations for LGMD2W; however, there is one active clinical trial aimed at exploring potential interventions. For more information on the trial, you can visit the ClinicalTrials.gov search page: https://clinicaltrials.gov/search?cond=autosomal%20recessive%20limb-girdle%20muscular%20dystrophy%20type%202W. This trial may provide insights into possible future treatment options.
Actionable guidance for navigating care for autosomal recessive limb-girdle muscular dystrophy type 2W
To navigate the challenges of LGMD2W, seek a neurologist with expertise in muscular dystrophies or neuromuscular disorders. It may also be beneficial to explore genetic counseling services to understand the implications of LIMS2 gene mutations for you and your family. While there are currently no patient organizations specifically for LGMD2W, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, consider participating in any available clinical trials to contribute to research and potentially access new treatment options.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.